New and proposed regulations will initiate seismic changes in Medicare and will have immense implications for healthcare stakeholders. These changes provide tremendous opportunities and challenges for Bio/Pharma Manufacturers.
In the midst of this uncertainty, the Strategic Medicare Contracting Forum provides insight into the newly proposed regulations and shines a light on what lies ahead.
CBI’s Strategic Medicare Contracting Forum brings together industry, policy and regulatory experts to discuss the impact of the new and proposed changes to the healthcare industry. Join colleagues and expert speakers to stay ahead of the curve on Medicare.